Lucia Faccio, Partner for the Sofinnova Telethon Fund at Sofinnova Partners talks about the recent creation of the Sofinnova Telethon Fund in Italy dedicated to early-stage investments in biotechnology companies that are addressing unmet medical needs of those suffering from rare and genetic diseases. Lucia is particularly enthusiastic about a recent investment in Genespire, company with a game changing technology providing a platform that is a lentiviral gene therapy for treatment of metabolic diseases and another gene editing platform with a focus on treating primary immunodeficiencies.
#SofinnovaPartners #Biotech #geneticdiseases #Funding
SofinnovaPartners.com
Download the transcript here
Empowered Patient Podcast